Minebase DS

Minebase DS may be available in the countries listed below.

Ingredient matches for Minebase DS

Clarithromycin

Clarithromycin is reported as an ingredient of Minebase DS in the following countries:

• Japan

International Drug Name Search

Pentoxifyllin Stada

Pentoxifyllin Stada may be available in the countries listed below.

Ingredient matches for Pentoxifyllin Stada

Pentoxifylline

Pentoxifylline is reported as an ingredient of Pentoxifyllin Stada in the following countries:

• Germany

International Drug Name Search

Bicalutamide-GA

Bicalutamide-GA may be available in the countries listed below.

Ingredient matches for Bicalutamide-GA

Bicalutamide

Bicalutamide is reported as an ingredient of Bicalutamide-GA in the following countries:

• Australia

International Drug Name Search

Valitazin

Valitazin may be available in the countries listed below.

Ingredient matches for Valitazin

Valsartan

Valsartan is reported as an ingredient of Valitazin in the following countries:

• Poland

International Drug Name Search

Pethidin.Sintetica

Pethidin.Sintetica may be available in the countries listed below.

Ingredient matches for Pethidin.Sintetica

Pethidine

Pethidine hydrochloride (a derivative of Pethidine) is reported as an ingredient of Pethidin.Sintetica in the following countries:

• Switzerland

International Drug Name Search

Memento

Memento may be available in the countries listed below.

Ingredient matches for Memento

Pipemidic Acid

Pipemidic Acid is reported as an ingredient of Memento in the following countries:

• Argentina

International Drug Name Search

Sorel

Sorel may be available in the countries listed below.

Ingredient matches for Sorel

Calcipotriol

Calcipotriol is reported as an ingredient of Sorel in the following countries:

• Bosnia & Herzegowina


• Poland


• Romania


• Slovenia

International Drug Name Search

Cincocaina

Cincocaina may be available in the countries listed below.

Ingredient matches for Cincocaina

Cinchocaine

Cincocaina (DCIT) is also known as Cinchocaine (Rec.INN)

International Drug Name Search

Glossary

DCIT	Denominazione Comune Italiana
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Calcefor Lch

Calcefor Lch may be available in the countries listed below.

Ingredient matches for Calcefor Lch

Calcium Carbonate

Calcium Carbonate is reported as an ingredient of Calcefor Lch in the following countries:

• Peru

International Drug Name Search

Fuzol Pauly

Fuzol Pauly may be available in the countries listed below.

Ingredient matches for Fuzol Pauly

Fluconazole

Fluconazole is reported as an ingredient of Fuzol Pauly in the following countries:

• Colombia


• Peru

International Drug Name Search

Enalapril / HCT-Teva

Enalapril/HCT-Teva may be available in the countries listed below.

Ingredient matches for Enalapril/HCT-Teva

Enalapril

Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Enalapril/HCT-Teva in the following countries:

• Germany


• Switzerland

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Enalapril/HCT-Teva in the following countries:

• Germany


• Switzerland

International Drug Name Search

Qualimintic

Qualimintic may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Qualimintic

Ivermectin

Ivermectin is reported as an ingredient of Qualimintic in the following countries:

• United Kingdom

International Drug Name Search

Platidiam

Platidiam may be available in the countries listed below.

Ingredient matches for Platidiam

Cisplatin

Cisplatin is reported as an ingredient of Platidiam in the following countries:

• Czech Republic


• Georgia


• Hungary


• Poland


• Romania


• Russian Federation


• Serbia


• Slovakia

International Drug Name Search

Betamenol

Betamenol may be available in the countries listed below.

Ingredient matches for Betamenol

Carteolol

Carteolol hydrochloride (a derivative of Carteolol) is reported as an ingredient of Betamenol in the following countries:

• Japan

International Drug Name Search

Nor-kilos

Nor-kilos may be available in the countries listed below.

Ingredient matches for Nor-kilos

Sibutramine

Sibutramine hydrochloride monohydrate (a derivative of Sibutramine) is reported as an ingredient of Nor-kilos in the following countries:

• El Salvador

International Drug Name Search

Lidocaina Cloridrato Monico

Lidocaina Cloridrato Monico may be available in the countries listed below.

Ingredient matches for Lidocaina Cloridrato Monico

Lidocaine

Lidocaine hydrochloride (a derivative of Lidocaine) is reported as an ingredient of Lidocaina Cloridrato Monico in the following countries:

• Italy

International Drug Name Search

ReoPro

Pronunciation: ab-SIKS-ih-mab
Generic Name: Abciximab
Brand Name: ReoPro

ReoPro is used for:

Preventing the formation of blood clots in the heart that may occur during procedures to open blocked arteries in the heart known as percutaneous coronary intervention (eg, balloon angioplasty, atherectomy, stent placement). It is also used in patients who have severe chest pain with heart disease (unstable angina) when percutaneous coronary intervention is planned. ReoPro is used in combination with other medicines.

ReoPro is an antithrombotic. It works by preventing the clumping of blood-clotting cells (called platelets) in the blood.

Do NOT use ReoPro if:

• you are allergic to any ingredient in ReoPro or to specific disease-fighting protein substances called murine (mouse) monoclonal antibodies


• you have had active internal bleeding; recent (within 6 weeks) gastrointestinal or genitourinary bleeding; trauma (within 2 years) to your head or spine; high blood pressure or problems with your blood, including bleeding easily or a stroke; low blood platelet count (known as thrombocytopenia); or recent (within 6 weeks) major surgery or trauma


• you have had a growth or cancer of the brain or problems with blood vessels in the brain, blood vessel inflammation (vasculitis), or problems with your eyes, liver, or kidneys


• you are or will be receiving dextran by injection


• you are receiving or have received an anticoagulant (eg, warfarin) within the last 7 days

Contact your doctor or health care provider right away if any of these apply to you.

Before using ReoPro:

Some medical conditions may interact with ReoPro. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have stomach ulcers or other stomach conditions


• if you have clotting or blood disorders

Some MEDICINES MAY INTERACT with ReoPro. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Anticoagulants (eg, warfarin, heparin) within the last 7 days, dipyridamole, nonsteroidal anti-inflammatory drugs (NSAIDs) (eg, ibuprofen), ticlopidine, or thrombolytics (t-PA) because the risk of bleeding may be increased

This may not be a complete list of all interactions that may occur. Ask your health care provider if ReoPro may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use ReoPro:

Use ReoPro as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• ReoPro is usually administered as an injection at your doctor's office, hospital, or clinic. If you are using ReoPro at home, carefully follow the injection procedures taught to you by your health care provider.


• If ReoPro contains particles or is discolored, or if the vial is cracked or damaged in any way, do not use it.


• Keep this product, as well as syringes and needles, out of the reach of children. Do not reuse needles, syringes, or other materials. Dispose of properly after use. Ask your doctor, nurse, or pharmacist to explain local regulations for proper disposal.


• If you miss a dose of ReoPro, contact your doctor right away.

Ask your health care provider any questions you may have about how to use ReoPro.

Important safety information:

• ReoPro may cause dizziness. Do not drive, operate machinery, or do anything else that could be dangerous until you know how you react to ReoPro. Using ReoPro alone, with certain other medicines, or with alcohol may lessen your ability to drive or to perform other potentially dangerous tasks.


• ReoPro may reduce the number of blood cells that are needed for clotting. To prevent bleeding, avoid situations in which bruising or injury may occur. Report any unusual bleeding, bruising, blood in stools, or dark, tarry stools to your doctor.


• LAB TESTS, including blood counts and blood clotting tests, may be performed to monitor your progress or to check for side effects. Be sure to keep all doctor and lab appointments.


• ReoPro is not recommended for use in CHILDREN; safety and effectiveness have not been confirmed.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, discuss with your doctor the benefits and risks of using ReoPro during pregnancy. It is unknown if ReoPro is excreted in breast milk. Do not breast-feed while taking ReoPro.

Possible side effects of ReoPro:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Back pain; dizziness; general pain; headache; indigestion; nausea; pain at injection site; slow heart rate; stomach pain; swelling; vomiting.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); abdominal pain or swelling; black or bloody stools; chest pain; chills; continued redness or pain after an injection; coughing up blood; excessive or unusual bleeding; fever; increased menstrual bleeding; nosebleeds; pink or red urine; severe headache; slow heartbeat; vomiting blood or material that looks like coffee grounds.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: ReoPro side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.

Proper storage of ReoPro:

Store ReoPro between 36 and 46 degrees F (2 and 8 degrees C). Do not freeze. Do not shake. Discard any unused portion left in the vial. Keep ReoPro out of the reach of children and away from pets.

General information:

• If you have any questions about ReoPro, please talk with your doctor, pharmacist, or other health care provider.


• ReoPro is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about ReoPro. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More ReoPro resources

• ReoPro Side Effects (in more detail)
• ReoPro Use in Pregnancy & Breastfeeding
• ReoPro Drug Interactions
• ReoPro Support Group
• 0 Reviews for ReoPro - Add your own review/rating

• ReoPro Prescribing Information (FDA)


• ReoPro Consumer Overview


• ReoPro Monograph (AHFS DI)


• Abciximab Professional Patient Advice (Wolters Kluwer)


• Reopro Advanced Consumer (Micromedex) - Includes Dosage Information

Compare ReoPro with other medications

• High Risk Percutaneous Transluminal Angioplasty

Strep-Deva

Strep-Deva may be available in the countries listed below.

Ingredient matches for Strep-Deva

Streptomycin

Streptomycin sulfate (a derivative of Streptomycin) is reported as an ingredient of Strep-Deva in the following countries:

• Turkey

International Drug Name Search

Aristocef

Aristocef may be available in the countries listed below.

Ingredient matches for Aristocef

Cefalexin

Cefalexin monohydrate (a derivative of Cefalexin) is reported as an ingredient of Aristocef in the following countries:

• Sri Lanka

International Drug Name Search

Sudafed Sinus Pain

Sudafed Sinus Pain may be available in the countries listed below.

Ingredient matches for Sudafed Sinus Pain

Paracetamol

Paracetamol is reported as an ingredient of Sudafed Sinus Pain in the following countries:

• South Africa

Pseudoephedrine

Pseudoephedrine hydrochloride (a derivative of Pseudoephedrine) is reported as an ingredient of Sudafed Sinus Pain in the following countries:

• South Africa

International Drug Name Search

Mintavit-C

Mintavit-C may be available in the countries listed below.

Ingredient matches for Mintavit-C

Ascorbic Acid

Ascorbic Acid is reported as an ingredient of Mintavit-C in the following countries:

• Chile

International Drug Name Search

Depnox

Depnox may be available in the countries listed below.

Ingredient matches for Depnox

Bupropion

Bupropion hydrochloride (a derivative of Bupropion) is reported as an ingredient of Depnox in the following countries:

• Bangladesh

International Drug Name Search